Literature DB >> 12183516

Susceptibility of interleukin-2-deficient mice to Toxoplasma gondii is associated with a defect in the production of gamma interferon.

Eric N Villegas1, Linda A Lieberman, Simon R Carding, Christopher A Hunter.   

Abstract

Costimulation through the B7-CD28 interaction is an important second signal for T-cell activation, and previous studies have shown that CD28(-/-) mice infected with Toxoplasma gondii generate suboptimal CD4(+) T-cell responses, associated with a defect in production of the T-cell growth factor interleukin-2 (IL-2). To address the role of IL-2 in the expansion of T cells during toxoplasmosis, IL-2(-/-) mice were infected with T. gondii and their ability to generate a protective T-cell response was assessed. Although IL-2(-/-) mice produced normal levels of IL-12p40, they had reduced levels of gamma interferon (IFN-gamma) in serum, had an increased parasite burden, and succumbed to infection with T. gondii within 20 days. Fluorescence-activated cell sorter analysis revealed that, although uninfected IL-2(-/-) mice had an increased number of activated T cells compared with uninfected IL-2(+/+) mice, following infection they were unable to further upregulate this population. Examination of the ability of splenocytes from uninfected and infected mice to produce IFN-gamma revealed that IL-2(-/-) mice were hyporesponsive to stimulation with anti-CD3 or parasite antigen compared with wild-type mice, and the addition of IL-2 alone or in combination with IL-12 or stimulation with phorbol myristate acetate and ionomycin did not restore the production of IFN-gamma. Together, these studies reveal that IL-2(-/-) mice are unable to generate a protective IFN-gamma response following infection with T. gondii and suggest that IL-2(-/-) mice have an intrinsic defect in their ability to activate and expand IFN-gamma-producing T cells required for resistance to T. gondii.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12183516      PMCID: PMC128219          DOI: 10.1128/IAI.70.9.4757-4761.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  27 in total

1.  Synergistic role of CD4+ and CD8+ T lymphocytes in IFN-gamma production and protective immunity induced by an attenuated Toxoplasma gondii vaccine.

Authors:  R T Gazzinelli; F T Hakim; S Hieny; G M Shearer; A Sher
Journal:  J Immunol       Date:  1991-01-01       Impact factor: 5.422

2.  CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines.

Authors:  C B Thompson; T Lindsten; J A Ledbetter; S L Kunkel; H A Young; S G Emerson; J M Leiden; C H June
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

3.  Immunohistological study of the anatomic relationship of toxoplasma antigens to the inflammatory response in the brains of mice chronically infected with Toxoplasma gondii.

Authors:  F K Conley; K A Jenkins
Journal:  Infect Immun       Date:  1981-03       Impact factor: 3.441

4.  The CD28/B7 interaction is not required for resistance to Toxoplasma gondii in the brain but contributes to the development of immunopathology.

Authors:  G Reichmann; E N Villegas; L Craig; R Peach; C A Hunter
Journal:  J Immunol       Date:  1999-09-15       Impact factor: 5.422

5.  Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway.

Authors:  T Lindstein; C H June; J A Ledbetter; G Stella; C B Thompson
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

6.  Differential T cell costimulatory requirements in CD28-deficient mice.

Authors:  A Shahinian; K Pfeffer; K P Lee; T M Kündig; K Kishihara; A Wakeham; K Kawai; P S Ohashi; C B Thompson; T W Mak
Journal:  Science       Date:  1993-07-30       Impact factor: 47.728

7.  Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene.

Authors:  B Sadlack; H Merz; H Schorle; A Schimpl; A C Feller; I Horak
Journal:  Cell       Date:  1993-10-22       Impact factor: 41.582

8.  Western Blot analysis of the antigens of Toxoplasma gondii recognized by human IgM and IgG antibodies.

Authors:  S D Sharma; J Mullenax; F G Araujo; H A Erlich; J S Remington
Journal:  J Immunol       Date:  1983-08       Impact factor: 5.422

9.  Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting.

Authors:  H Schorle; T Holtschke; T Hünig; A Schimpl; I Horak
Journal:  Nature       Date:  1991-08-15       Impact factor: 49.962

10.  Different regulation of the L3T4-T cell subset by B cells in different mouse strains bearing the H-2k haplotype.

Authors:  V Brinkmann; S D Sharma; J S Remington
Journal:  J Immunol       Date:  1986-11-01       Impact factor: 5.422

View more
  13 in total

1.  Responses to Leishmania donovani in mice deficient in interleukin-12 (IL-12), IL-12/IL-23, or IL-18.

Authors:  Henry W Murray; Christine W Tsai; Jianguo Liu; Xiaojing Ma
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

2.  Biological role of surface Toxoplasma gondii antigen in development of vaccine.

Authors:  Ke-Yi Liu; Dian-Bo Zhang; Qing-Kuan Wei; Jin Li; Gui-Ping Li; Jin-Zhi Yu
Journal:  World J Gastroenterol       Date:  2006-04-21       Impact factor: 5.742

Review 3.  The CD8 T-cell road to immunotherapy of toxoplasmosis.

Authors:  Rajarshi Bhadra; Jason P Gigley; Imtiaz A Khan
Journal:  Immunotherapy       Date:  2011-06       Impact factor: 4.196

Review 4.  CD8+ T cell immunity in an encephalitis model of Toxoplasma gondii infection.

Authors:  SuJin Hwang; Imtiaz A Khan
Journal:  Semin Immunopathol       Date:  2015-05-06       Impact factor: 9.623

5.  Localized multigene expression patterns support an evolving Th1/Th2-like paradigm in response to infections with Toxoplasma gondii and Ascaris suum.

Authors:  Harry D Dawson; Ethiopia Beshah; Sandra Nishi; Gloria Solano-Aguilar; Motoko Morimoto; Aiping Zhao; Kathleen B Madden; Tonya K Ledbetter; J P Dubey; Terez Shea-Donohue; Joan K Lunney; Joseph F Urban
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

6.  Trefoil factor 2 negatively regulates type 1 immunity against Toxoplasma gondii.

Authors:  Cortez McBerry; Charlotte E Egan; Reena Rani; Yanfen Yang; David Wu; Nicholas Boespflug; Louis Boon; Barbara Butcher; Julie Mirpuri; Simon P Hogan; Eric Y Denkers; Julio Aliberti; De'broski R Herbert
Journal:  J Immunol       Date:  2012-08-15       Impact factor: 5.422

7.  IL-2 produced by CD8+ immune T cells can augment their IFN-γ production independently from their proliferation in the secondary response to an intracellular pathogen.

Authors:  Qila Sa; Jerold Woodward; Yasuhiro Suzuki
Journal:  J Immunol       Date:  2013-01-28       Impact factor: 5.422

8.  T cell expression of MyD88 is required for resistance to Toxoplasma gondii.

Authors:  David F LaRosa; Jason S Stumhofer; Andrew E Gelman; Adeeb H Rahman; Devon K Taylor; Christopher A Hunter; Laurence A Turka
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-28       Impact factor: 11.205

9.  T cells need Nod too?

Authors:  Shahram Salek-Ardakani; Michael Croft
Journal:  Nat Immunol       Date:  2009-12       Impact factor: 25.606

10.  T cell-intrinsic role of Nod2 in promoting type 1 immunity to Toxoplasma gondii.

Authors:  Michael H Shaw; Thornik Reimer; Carmen Sánchez-Valdepeñas; Neil Warner; Yun-Gi Kim; Manuel Fresno; Gabriel Nuñez
Journal:  Nat Immunol       Date:  2009-11-01       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.